Sandra Forman

7.5k total citations
90 papers, 4.6k citations indexed

About

Sandra Forman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sandra Forman has authored 90 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Cardiology and Cardiovascular Medicine, 43 papers in Surgery and 36 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sandra Forman's work include Acute Myocardial Infarction Research (46 papers), Cardiac Imaging and Diagnostics (36 papers) and Coronary Interventions and Diagnostics (32 papers). Sandra Forman is often cited by papers focused on Acute Myocardial Infarction Research (46 papers), Cardiac Imaging and Diagnostics (36 papers) and Coronary Interventions and Diagnostics (32 papers). Sandra Forman collaborates with scholars based in United States, Canada and Poland. Sandra Forman's co-authors include Genell L. Knatterud, Michael L. Terrin, Hiltrud S. Mueller, George Sopko, Nancy L. Geller, Eugene Braunwald, Eugene Braunwald, Gary Gerstenblith, Anupama Rao and Carl J. Pepine and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Sandra Forman

89 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Forman United States	33	3.3k	1.7k	1.5k	461	365	90	4.6k
Raffaele Bugiardini Italy	35	4.3k 1.3×	1.6k 0.9×	1.9k 1.3×	252 0.5×	313 0.9×	157	5.5k
Jan Paul Ottervanger Netherlands	37	4.9k 1.5×	2.2k 1.3×	2.0k 1.3×	254 0.6×	267 0.7×	236	6.4k
Leonard Schwartz Canada	33	2.8k 0.8×	2.7k 1.6×	1.1k 0.8×	235 0.5×	714 2.0×	110	4.4k
Marc J. Claeys Belgium	26	3.3k 1.0×	1.7k 1.0×	823 0.5×	260 0.6×	267 0.7×	137	4.5k
Giovanni Parrinello Italy	36	3.3k 1.0×	1.9k 1.1×	688 0.5×	289 0.6×	641 1.8×	70	5.3k
Lars Romer Krusell Denmark	33	3.3k 1.0×	2.2k 1.2×	1.6k 1.0×	571 1.2×	594 1.6×	92	4.9k
John H. McAnulty United States	35	7.3k 2.2×	1.2k 0.7×	729 0.5×	641 1.4×	426 1.2×	115	8.4k
Bonnie H. Weiner United States	29	1.7k 0.5×	1.5k 0.9×	728 0.5×	263 0.6×	524 1.4×	83	3.1k
Osmund Bertel Switzerland	30	2.9k 0.9×	992 0.6×	506 0.3×	436 0.9×	475 1.3×	137	4.0k
Hanoch Hod Israel	39	5.2k 1.6×	2.0k 1.1×	1.5k 1.0×	276 0.6×	308 0.8×	155	6.0k

Countries citing papers authored by Sandra Forman

Since Specialization

Citations

This map shows the geographic impact of Sandra Forman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Forman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Forman more than expected).

Fields of papers citing papers by Sandra Forman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Forman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Forman. The network helps show where Sandra Forman may publish in the future.

Co-authorship network of co-authors of Sandra Forman

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Forman. A scholar is included among the top collaborators of Sandra Forman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Forman. Sandra Forman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Freixa, Xavier, Sandra Forman, James M. Rankin, et al.. (2011). 6-YEAR OUTCOMES OF PATIENTS TREATED WITH DES, BMS OR MEDICAL THERAPY IN THE OAT TRIAL. Journal of the American College of Cardiology. 57(14). E1833–E1833. 1 indexed citations

Udelson, James E., Carey Kimmelstiel, Mariusz Kruk, et al.. (2011). The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone. American Heart Journal. 161(3). 611–621. 25 indexed citations

Schulman, Steven P., David R. Thiemann, Pamela Ouyang, et al.. (2002). Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina. Journal of the American College of Cardiology. 39(2). 231–237. 47 indexed citations

Walenga, Jeanine M., Debra Hoppensteadt, Roque Pifarré, et al.. (2001). The Hemostatic Effects of Warfarin Titration in Post CABG Patients in Comparison to Placebo Treatment. Journal of Thrombosis and Thrombolysis. 11(2). 143–149. 2 indexed citations

Alaupovic, Petar, J.D. Fesmire, Michaël Domanski, et al.. (1999). The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial. Atherosclerosis. 146(2). 369–379. 23 indexed citations

Pepine, Carl J., Thomas Andrews, Sandra Forman, et al.. (1997). Relation Between Clinical, Angiographic and Ischemic Findings at Baseline and Ischemia-Related Adverse Outcomes at 1 Year in the Asymptomatic Cardiac Ischemia Pilot Study fn1fn1This study was funded by the National Heart, Lung, and Blood Institute, Cardiac Diseases Branch, Division of Heart and Vascular Diseases, National Institutes of Health, Bethesda, Maryland, by Research Contracts HV-90-07, HV90-08, HV-91-05 to HV-91-14. Study medications and placebo were donated by Zeneca Pharmaceuticals Group, Wilmington, Delaware; Marion-Merrell Dow, Kansas City, Missouri; and Pfizer, New York, New York. Support for electrocardiographic data collection was provided in part by Applied Cardiac Systems, Laguna Hills, California; Marquette Electronics, Milwaukee, Wisconsin; Mortara Instrument, Milwaukee, Wisconsin; and Quinton Instruments, Seattle, Washington. Some centers had partial support from grants from the General Clinical Research Center, National Institutes of Health.. Journal of the American College of Cardiology. 29(7). 1483–1489. 26 indexed citations

Mahmarian, John J., Richard M. Steingart, Sandra Forman, et al.. (1997). Relation Between Ambulatory Electrocardiographic Monitoring and Myocardial Perfusion Imaging to Detect Coronary Artery Disease and Myocardial Ischemia: An ACIP Ancillary Study. Journal of the American College of Cardiology. 29(4). 764–769. 12 indexed citations

Conti, C. Richard, Nancy L. Geller, Genell L. Knatterud, et al.. (1997). Anginal Status and Prediction of Cardiac Events in Patients Enrolled in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. The American Journal of Cardiology. 79(7). 889–892. 3 indexed citations

Pepine, Carl J., Thomas Andrews, John Deanfield, et al.. (1996). Relation of patient characteristics to cardiac ischemia during daily life activity (an Asymptomatic Cardiac Ischemia Pilot data bank study). The American Journal of Cardiology. 77(15). 1267–1272. 3 indexed citations

10.

Bourassa, Martial G., Carl J. Pepine, Sandra Forman, et al.. (1995). Asymptomatic cardiac ischemia pilot (ACIP) study: Effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. Journal of the American College of Cardiology. 26(3). 606–614. 31 indexed citations

11.

Rogers, W J, Martial G. Bourassa, Thomas Andrews, et al.. (1995). Asymptomatic cardiac ischemia pilot (ACIP) study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. Journal of the American College of Cardiology. 26(3). 594–605. 110 indexed citations

12.

Sloan, M. A., T R Price, Carol K. Petito, et al.. (1995). Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction. Neurology. 45(4). 649–658. 85 indexed citations

13.

Chaitman, Bernard, Peter H. Stone, Genell L. Knatterud, et al.. (1995). Asymptomatic cardiac ischemia pilot (ACIP) study: Impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. Journal of the American College of Cardiology. 26(3). 585–593. 28 indexed citations

14.

Cox, David A., William J. Rogers, Frank V. Aguirre, et al.. (1994). Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The American Journal of Cardiology. 73(11). 729–736. 12 indexed citations

15.

Muller, James E., Peter H. Stone, Sandra Forman, et al.. (1992). Modifiers of timing and possible triggers of acute myocardial infarction in the thrombolysis in myocardial infarction phase II (TIMI II) study group. Journal of the American College of Cardiology. 20(5). 1049–1055. 142 indexed citations

16.

Hillis, L. David, Sandra Forman, & Eugene Braunwald. (1990). Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. Journal of the American College of Cardiology. 16(2). 313–315. 106 indexed citations

17.

Rogers, William J., Robert C. Bourge, Silvio E. Papapietro, et al.. (1989). Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study. The American Journal of Cardiology. 63(9). 503–512. 11 indexed citations

18.

Mueller, Hiltrud S., Anupama Rao, & Sandra Forman. (1987). Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator. Journal of the American College of Cardiology. 10(3). 479–490. 187 indexed citations

19.

Passamani, Eugene R., Morrison Hodges, Michael V. Herman, et al.. (1987). The thrombolysis in myocardial infarction (TIMI) phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty. Journal of the American College of Cardiology. 10(5). 51B–64B. 85 indexed citations

20.

Forman, Sandra, H. Kodama, & S Abbey. (1967). A re-examination of xanthophyllite (clintonite) from the type locality. The Canadian Mineralogist. 9(1). 25–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact